The U.S. Food and Drug Administration (FDA) has awarded Breakthrough Therapy Designation to Cogent Biosciences, Inc. for its innovative treatment combining bezuclastinib with sunitinib...
A wave of investor enthusiasm propelled ten companies to remarkable weekly gains, with some stocks witnessing increases of over 100 percent. This surge, driven...